D
BioLife Solutions, Inc. BLFS
NASDAQ
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
D
Sell 4/6/2023Downgrade
BioLife Solutions, Inc. (BLFS) was downgraded to D- from D on 4/6/2023 due to a major decline in the solvency index, growth index and total return index. Earnings per share declined from -$0.2335 to -$1.1766, EBIT declined 20.69% from -$9.06M to -$10.93M, and the quick ratio declined from 2.55 to 2.17.
D
Sell 5/16/2022Upgraded
BioLife Solutions, Inc. (BLFS) was upgraded to D from E+ on 05/16/2022.
E
Sell 5/13/2022Downgrade
BioLife Solutions, Inc. (BLFS) was downgraded to E+ from D on 5/13/2022 due to a major decline in the efficiency index, volatility index and total return index. Total capital declined 0.5% from $507.02M to $504.51M.
D
Sell 3/15/2022Downgrade
BioLife Solutions, Inc. (BLFS) was downgraded to D from D+ on 3/15/2022 due to a noticeable decline in the total return index and volatility index.
D
Sell 11/30/2021Downgrade
BioLife Solutions, Inc. (BLFS) was downgraded to D+ from C on 11/30/2021 due to a significant decline in the total return index.
C
Hold 11/22/2021Upgraded
BioLife Solutions, Inc. (BLFS) was upgraded to C from C- on 11/22/2021 due to an increase in the efficiency index, total return index and growth index. Operating cash flow increased 126.97% from -$7.72M to $2.08M, total revenue increased 8.32% from $31.2M to $33.8M, and total capital increased 7.41% from $481.8M to $517.48M.
C
Hold 11/3/2021Upgraded
BioLife Solutions, Inc. (BLFS) was upgraded to C- from D+ on 11/3/2021 due to a large increase in the total return index and volatility index.
D
Sell 10/4/2021Downgrade
BioLife Solutions, Inc. (BLFS) was downgraded to D+ from C- on 10/4/2021 due to a large decline in the total return index.
C
Hold 8/20/2021Upgraded
BioLife Solutions, Inc. (BLFS) was upgraded to C- from D on 8/20/2021 due to a significant increase in the total return index, valuation index and efficiency index. Net income increased 804.47% from -$1.12M to $7.88M, and total capital increased 116.8% from $222.23M to $481.8M.
D
Sell 4/26/2021Downgrade
BioLife Solutions, Inc. (BLFS) was downgraded to D from D+ on 4/26/2021 due to a large decline in the total return index.
D
Sell 4/7/2021Upgraded
BioLife Solutions, Inc. (BLFS) was upgraded to D+ from D on 4/7/2021 due to a noticeable increase in the efficiency index and volatility index. Total capital increased 15.34% from $187.61M to $216.4M.
D
Sell 11/16/2020Downgrade
BioLife Solutions, Inc. (BLFS) was downgraded to D from D+ on 11/16/2020 due to a major decline in the efficiency index.
D
Sell 9/24/2020Upgraded
BioLife Solutions, Inc. (BLFS) was upgraded to D+ from D on 9/24/2020 due to an increase in the total return index, solvency index and volatility index.
D
Sell 8/13/2020Downgrade
BioLife Solutions, Inc. (BLFS) was downgraded to D from C- on 8/13/2020 due to a significant decline in the growth index and efficiency index. EBIT declined 267.03% from $728 to -$1.22M, earnings per share declined from $0.5419 to -$0.7032, and net income declined 173.43% from $22.31M to -$16.38M.
C
Hold 5/29/2020Upgraded
BioLife Solutions, Inc. (BLFS) was upgraded to C- from D on 5/29/2020 due to a significant increase in the growth index, efficiency index and total return index. EBIT increased 349.32% from -$292 to $728, net income increased 282.28% from -$12.24M to $22.31M, and operating cash flow increased 168.49% from -$1M to $687.
D
Sell 5/15/2020Downgrade
BioLife Solutions, Inc. (BLFS) was downgraded to D from C on 5/15/2020 due to a significant decline in the growth index, valuation index and efficiency index. Earnings per share declined from $0.37 to -$0.5937, net income declined 231.37% from $9.32M to -$12.24M, and operating cash flow declined 188.21% from $1.14M to -$1M.
C
Hold 11/13/2019Upgraded
BioLife Solutions, Inc. (BLFS) was upgraded to C from C- on 11/13/2019 due to a significant increase in the valuation index, efficiency index and growth index. Operating cash flow increased 1,797.01% from -$67 to $1.14M, earnings per share increased from $0.03 to $0.37, and net income increased 1,011.69% from $838 to $9.32M.
C
Hold 9/24/2019Downgrade
BioLife Solutions, Inc. (BLFS) was downgraded to C- from C on 9/24/2019 due to a large decline in the total return index and valuation index.
C
Hold 8/13/2019Upgraded
BioLife Solutions, Inc. (BLFS) was upgraded to C from C- on 8/13/2019 due to a major increase in the growth index, efficiency index and solvency index. Net income increased 96.25% from $427 to $838, EBIT increased 51.79% from $699 to $1.06M, and earnings per share increased from $0.02 to $0.03.
C
Hold 8/2/2019Upgraded
BioLife Solutions, Inc. (BLFS) was upgraded to C- from D+ on 8/2/2019 due to a major increase in the total return index.
D
Sell 7/18/2019Downgrade
BioLife Solutions, Inc. (BLFS) was downgraded to D+ from C- on 7/18/2019 due to a major decline in the total return index.
C
Hold 6/24/2019Downgrade
BioLife Solutions, Inc. (BLFS) was downgraded to C- from C on 6/24/2019 due to a noticeable decline in the total return index and growth index. Earnings per share declined from $0.0389 to $0.02, and EBIT declined 32.95% from $1.04M to $699.
C
Hold 3/13/2019Upgraded
BioLife Solutions, Inc. (BLFS) was upgraded to C from C- on 3/13/2019 due to a significant increase in the total return index.
C
Hold 3/4/2019Upgraded
BioLife Solutions, Inc. (BLFS) was upgraded to C- from D+ on 3/4/2019 due to an increase in the total return index.
D
Sell 1/14/2019Downgrade
BioLife Solutions, Inc. (BLFS) was downgraded to D+ from C- on 1/14/2019 due to a decline in the valuation index, total return index and volatility index.
C
Hold 12/28/2018Upgraded
BioLife Solutions, Inc. (BLFS) was upgraded to C- from D+ on 12/28/2018 due to an increase in the valuation index.
D
Sell 12/13/2018Downgrade
BioLife Solutions, Inc. (BLFS) was downgraded to D+ from C- on 12/13/2018 due to a significant decline in the total return index, growth index and volatility index. EBIT declined 6.99% from $1.28M to $1.2M.
C
Hold 10/3/2018Downgrade
BioLife Solutions, Inc. (BLFS) was downgraded to C- from C on 10/3/2018 due to a decline in the total return index and volatility index.
C
Hold 8/28/2018Upgraded
BioLife Solutions, Inc. (BLFS) was upgraded to C from D on 8/28/2018 due to a major increase in the growth index, efficiency index and solvency index. Net income increased 32,448.57% from $3.5 to $1.14M, EBIT increased 819.69% from $139.7 to $1.28M, and earnings per share increased from -$0.0073 to $0.05.
D
Sell 1/23/2018Upgraded
BioLife Solutions, Inc. (BLFS) was upgraded to D from D- on 1/23/2018 due to a noticeable increase in the total return index, volatility index and valuation index.
D
Sell 1/8/2018Downgrade
BioLife Solutions, Inc. (BLFS) was downgraded to D- from D on 1/8/2018 due to a decline in the volatility index and valuation index.
D
Sell 12/8/2017Upgraded
BioLife Solutions, Inc. (BLFS) was upgraded to D from D- on 12/8/2017 due to a significant increase in the total return index, growth index and solvency index. Operating cash flow increased 172.3% from -$102.9 to $74.4, EBIT increased 90.53% from -$341.2 to -$32.3, and earnings per share increased from -$0.0586 to -$0.0321.
D
Sell 6/2/2016Downgrade
BioLife Solutions, Inc. (BLFS) was downgraded to D- from D on 6/2/2016 due to a noticeable decline in the total return index, efficiency index and growth index. Operating cash flow declined 25.44% from -$1.27M to -$1.59M, total capital declined 13.49% from $9.86M to $8.53M, and net income declined 9.59% from -$1.12M to -$1.23M.
D
Sell 3/11/2016Downgrade
BioLife Solutions, Inc. (BLFS) was downgraded to D from D+ on 3/11/2016 due to a substantial decline in the volatility index, total return index and growth index. Operating cash flow declined 8.7% from -$1.17M to -$1.27M, EBIT declined 8.32% from -$1.3M to -$1.4M, and earnings per share declined from -$0.0879 to -$0.091.
D
Sell 2/1/2016Downgrade
BioLife Solutions, Inc. (BLFS) was downgraded to D+ from C- on 2/1/2016 due to a substantial decline in the volatility index.
C
Hold 11/30/2015Upgraded
BioLife Solutions, Inc. (BLFS) was upgraded to C- from D+ on 11/30/2015 due to an increase in the total return index and growth index.
D
Sell 11/13/2015Downgrade
BioLife Solutions, Inc. (BLFS) was downgraded to D+ from C- on 11/13/2015 due to a decline in the growth index, total return index and efficiency index. Total capital declined 9.2% from $11.88M to $10.78M, and operating cash flow declined 4.77% from -$1.23M to -$1.17M.
C
Hold 8/31/2015Upgraded
BioLife Solutions, Inc. (BLFS) was upgraded to C- from D+ on 8/31/2015 due to a substantial increase in the volatility index, growth index and total return index.
D
Sell 5/8/2015Downgrade
BioLife Solutions, Inc. (BLFS) was downgraded to D+ from C- on 5/8/2015 due to a noticeable decline in the efficiency index, volatility index and growth index. Total revenue declined 10.16% from $1.67M to $1.5M, and total capital declined 7.81% from $13.94M to $12.85M.
C
Hold 4/27/2015Downgrade
BioLife Solutions, Inc. (BLFS) was downgraded to C- from C on 4/27/2015 due to a large decline in the volatility index, total return index and solvency index. The quick ratio declined from 14.16 to 8.59.
C
Hold 5/20/2014Downgrade
BioLife Solutions, Inc. (BLFS) was downgraded to C from C+ on 5/20/2014 due to a major decline in the efficiency index, growth index and volatility index. Operating cash flow declined 1,238.98% from $78.5 to -$894.1, total capital declined 627.55% from -$2.67M to $14.08M, and total revenue declined 9.78% from $2.29M to $2.07M.
C
Hold 4/30/2014Upgraded
BioLife Solutions, Inc. (BLFS) was upgraded to C+ from C on 4/30/2014 due to a noticeable increase in the valuation index and solvency index. Debt to equity declined from -0.82 to -0.8.
Weiss Ratings